Paul Fields

4.4k total citations · 1 hit paper
44 papers, 2.7k citations indexed

About

Paul Fields is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Paul Fields has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Paul Fields's work include CAR-T cell therapy research (14 papers), Virus-based gene therapy research (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Paul Fields is often cited by papers focused on CAR-T cell therapy research (14 papers), Virus-based gene therapy research (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Paul Fields collaborates with scholars based in United States, United Kingdom and Germany. Paul Fields's co-authors include Roland W. Herzog, Katherine A. High, Laurie A. Boyer, J. Nathan Hagstrom, Valder R. Arruda, Linda B. Couto, Lauren E. Surface, Vincent L. Butty, Timothy C. Nichols and Robert K. Bradley and has published in prestigious journals such as Cell, Circulation and Nature Medicine.

In The Last Decade

Paul Fields

42 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment

2013 733 citations Carla Klattenhoff, Johanna C. Scheuermann et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Fields United States	21	1.9k	1.1k	732	638	227	44	2.7k
Ailsa Webster United Kingdom	18	1.0k 0.5×	496 0.4×	708 1.0×	601 0.9×	149 0.7×	22	2.0k
Stephanie Sellers United States	24	1.4k 0.7×	1.3k 1.1×	734 1.0×	343 0.5×	279 1.2×	46	2.5k
Samuel L. Murphy United States	13	1.5k 0.8×	1.2k 1.1×	528 0.7×	88 0.1×	177 0.8×	27	2.0k
E G Nabel United States	17	1.6k 0.8×	998 0.9×	357 0.5×	169 0.3×	428 1.9×	20	2.4k
Linda Wolff United States	34	1.9k 1.0×	641 0.6×	733 1.0×	536 0.8×	671 3.0×	105	3.2k
Archibald S. Perkins United States	22	1.2k 0.6×	346 0.3×	425 0.6×	161 0.3×	255 1.1×	42	2.3k
Robert W. Overell United States	20	1.6k 0.8×	839 0.7×	784 1.1×	225 0.4×	893 3.9×	27	2.8k
Dirk M. Nettelbeck Germany	36	2.2k 1.1×	2.2k 1.9×	1.6k 2.2×	170 0.3×	549 2.4×	83	3.4k
Robert Strauss United States	23	1.3k 0.7×	744 0.7×	939 1.3×	187 0.3×	284 1.3×	38	2.4k
Geoff Symonds Australia	25	1.5k 0.8×	648 0.6×	389 0.5×	109 0.2×	409 1.8×	98	2.2k

Countries citing papers authored by Paul Fields

Since Specialization

Citations

This map shows the geographic impact of Paul Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fields more than expected).

Fields of papers citing papers by Paul Fields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fields. The network helps show where Paul Fields may publish in the future.

Co-authorship network of co-authors of Paul Fields

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Fields. A scholar is included among the top collaborators of Paul Fields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Fields. Paul Fields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banbury, Barbara L., Jie He, Paul Fields, et al.. (2025). Pre-transplant T-cell clonal analysis identifies CD8+ donor reactive clones that contribute to kidney transplant rejection. Frontiers in Immunology. 16. 1516772–1516772.

Mallory, Michael L., Jennifer E. Munt, Tara M. Narowski, et al.. (2024). COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort. Science Advances. 10(24). eadi1379–eadi1379.

Nawrocki, Steffan T., Kaijin Wu, Denice Tsao‐Wei, et al.. (2023). Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial. Clinical Cancer Research. 29(24). 5087–5103. 6 indexed citations

Greenberger, Lee M., Larry A. Saltzman, Lore Gruenbaum, et al.. (2022). Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies. Blood Cancer Discovery. 3(6). 481–489. 9 indexed citations

Sigdel, Tara K., Paul Fields, Juliane Liberto, et al.. (2022). Perturbations of the T-cell immune repertoire in kidney transplant rejection. Frontiers in Immunology. 13. 1012042–1012042. 3 indexed citations

Swanson, Phillip A., Marcelino Padilla, Kelly McGlinchey, et al.. (2021). AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T _H 1 response with a diverse TCR repertoire. Science Translational Medicine. 13(620). eabj7211–eabj7211. 59 indexed citations

Skarbnik, Alan P, Michèle L. Donato, Rena Feinman, et al.. (2020). Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(5). 391–403. 8 indexed citations

Rytlewski, Julie, James S. Wilmott, Martín C. Mihm, et al.. (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature Cancer. 1(2). 197–209. 19 indexed citations

Abel, Kathryn M. Van, David M. Routman, Eric J. Moore, et al.. (2020). T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma. Oral Oncology. 111. 104894–104894. 10 indexed citations

10.

Zaunbrecher, Rebecca J., Kevin M. Beussman, Andrea Leonard, et al.. (2019). Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function. Circulation. 140(20). 1647–1660. 49 indexed citations

11.

Mahalingam, Devalingam, Grey Wilkinson, Kevin H. Eng, et al.. (2019). Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study. Clinical Cancer Research. 26(1). 71–81. 142 indexed citations

12.

Bertero, Alessandro, Paul Fields, Alec S.T. Smith, et al.. (2019). Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy. The Journal of Cell Biology. 218(9). 2919–2944. 48 indexed citations

13.

Chang, Li‐Wei, Linda Doan, Paul Fields, Marissa Vignali, & Oleg E. Akilov. (2019). The Utility of T-Cell Clonality in Differential Diagnostics of Acute Graft-versus-Host Disease from Drug Hypersensitivity Reaction. Journal of Investigative Dermatology. 140(6). 1282–1285. 3 indexed citations

14.

Bertero, Alessandro, Paul Fields, Vijay Ramani, et al.. (2019). Dynamics of genome reorganization during human cardiogenesis reveal an RBM20-dependent splicing factory. Nature Communications. 10(1). 1538–1538. 89 indexed citations

15.

Subramanian, Vidya, Paul Fields, & Laurie A. Boyer. (2015). H2A.Z: a molecular rheostat for transcriptional control. F1000Prime Reports. 7. 1–1. 80 indexed citations

16.

Klattenhoff, Carla, Johanna C. Scheuermann, Lauren E. Surface, et al.. (2013). Braveheart, a Long Noncoding RNA Required for Cardiovascular Lineage Commitment. Cell. 152(3). 570–583. 733 indexed citations breakdown →

17.

Barone, Francesca, Anna Vossenkämper, Laurent Boursier, et al.. (2010). IgA-Producing Plasma Cells Originate From Germinal Centers That Are Induced by B-Cell Receptor Engagement in Humans. Gastroenterology. 140(3). 947–956. 52 indexed citations

18.

Nelson, Angelique M., Paul Fields, Jennifer Hesson, et al.. (2008). Diverse hematopoietic potentials of five human embryonic stem cell lines. Experimental Cell Research. 314(16). 2930–2940. 40 indexed citations

19.

Streetly, Matthew, M. G. Macey, D. McCarthy, et al.. (2003). Changes in neutrophil phenotype following the administration of CC-4047 (Actimid) to patients with multiple myeloma.. Blood. 102(11). 1 indexed citations

20.

Fields, Paul & John Pasi. (1998). Gene therapy for haemophilia: how far have we come?. Haemophilia. 4(5). 699–703. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact